Skip to main content

Advertisement

Table 4 Distribution of the cytological and pathological results from the 23 false-negative cases

From: Can concurrent core biopsy and fine needle aspiration biopsy improve the false negative rate of sonographically detectable breast lesions?

Patient Nr. U FNAB U/F CNB Final Pathology  
1 S M SM ADH DCIS *
2 S S SS Papilloma IDC  
3 I I II Fibrocystic change DCIS  
4 B M BM Fibrocystic change IDC *
5 S M SM ADH Apocrine CA *
6 I M IM Fibroadipose tissue IDC *
7 M M MM Lactating adenosis IDC *
8 I I II Papilloma DCIS  
9 I M IM Papilloma IPC *
10 I I II Papilloma IDC  
11 S M SM Atypical cell IDC  
12 S M SM Fibrocystic change IDC *
13 S M SM Sclerosing adenosis IDC *
14 S M SM Chronic inflammation IDC *
15 M I MI Fibrocystic change IDC  
16 S M SM ADH IDC *
17 I I II Papilloma IDC  
18 I I II Papilloma DCIS  
19 I M IM Fibrous mastopathy DCIS *
20 I M IM No evidence of malignancy Mucinous carcinoma *
21 S M SM ADH DCIS  
22 S M SM Papillary lesion Mucinous CA *
23 I I II Fibrocystic change IDC  
  1. * Cases detected by fine needle aspiration biopsy
  2. U: Ultrasound
  3. U/F: Ultrasound/fine needle aspiration biopsy
  4. B: Benign, I: Benign, but uncertain malignant potential, S: Suspicious of malignancy, M: Malignant, ADH: atypical ductal hyperplasia, DCIS: ductal carcinoma in situ, IDC: invasive ductal carcinoma, IPC: invasive papillary carcinoma